Table 4.
Factor | Non-cirrhotics | Cirrhotics | Statistics | P value |
Clinical success | 23 (92.0) | 3 (60.0) | -32.0 (-75.2, 18.3) | 0.12d |
Successful stent removal following resolution | 20 (80.0) | 3 (60.0) | -20.0 (-71.6, 29.9) | 0.57d |
Total number of endoscopic procedures prior to removal | 1.5 ± 0.94 | 2.0 ± 1.7 | 0.55 (-0.80, 1.9) | 0.41a |
ERCP performed within 30 d post drainage | 5 (20.0) | 1 (20.0) | 0.00 (-52.2, 52.2) | 0.99d |
Recurrence of PFC needing reintervention | 4 (16.0) | 0 (0.0) | -16.0 (-60.1, 37.5) | 0.99d |
Need for surgery | 2 (8.0) | 0 (0.0) | -8.0 (-56.2, 41.3) | 0.99d |
Any adverse events | 7 (28.0) | 3 (60.0) | 12.0 (-37.5, 60.1) | 0.62d |
Bleeding | 1 (4.0) | 1 (20.0) | 16.0 (-33.8, 64.4) | 0.31d |
Infection | 5 (20.0) | 2 (40.0) | 20.0 (-29.9, 71.6) | 0.57d |
Stent migration | 1 (4.0) | 0 (0.0) | -4.0 (-52.4, 45.0) | 0.99d |
Any severe AE | 2 (8.0) | 0 (0.0) | -8.0 (-56.2, 41.3) | 0.99d |
Any fatal AE | 0 (0.0) | 2 (40.0) | 40.0 (-10.3, 85.3) | 0.023d |
Any severe/fatal AE | 2 (8.0) | 2 (40.0) | 32.0 (-18.3, 75.2) | 0.12d |
Length of post-procedure hospitalization (d) | 5.6 ± 13.7 | 18.6 ± 20.3 | 13.0 (-1.9, 27.9) | 0.084a |
Follow-up (mo) | 14.1 ± 9.5 | 5.5 ± 5.1 | -8.6 (-17.6, 0.49) | 0.063a |
Statistics presented as mean ± SD or n (%). P values:
ANOVA; bFisher’s exact test. AE: Adverse event; ERCP: Endoscopic retrograde cholangiopancreatography; PFC: Pancreatic fluid collection.